Insurers won't cover new Alzheimer's treatment for some
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.
Source: wmur.com
Stay updated with breaking news from James Chambers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.